Abiopharma

STERIS PLC (STE) Reports the reporting period Financial Results STERIS PLC (STE) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 26
• Net Income: $220
• EPS: 2.24
• Cash and equivalents: $1.34 billion
  • expected integration costs or difficulties in connection with the integration of acquired businesses. Unless legally required, STERIS does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized.STERIS plcConsolidated Condensed Statements of Operations(Unaudited - In millions, except per share data)Three Months Ended March 31, Twelve Months Ended March 31, 2026